Clinical Trials
5 trialsNCT07395804 2026-05-29
23146
Bayer
Recruiting
NCT06661122 2026-05-19
HAYATE
Bayer
Recruiting
NCT07241416 2026-05-11
A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Recruiting
NCT06010914 2026-04-15
DADOX
Bayer
Active not recruiting
NCT06392841 2026-04-08
HARMONY
Hoosier Cancer Research Network
Phase 2 Withdrawn